SEATTLE - For the first time ever, there's a cancer treatment vaccine on the market, and a Seattle company is behind it. The biotech company Dendreon got approval Thursday from the Food and Drug ...
New research in Seattle supports a surprising link between a common health supplement and a dramatically increased risk of prostate cancer. It’s omega-3 fatty acids, derived from fatty fish and fish ...
First comprehensive assessment of DNA errors that drive advanced prostate cancer SEATTLE - A team of researchers at Fred Hutchinson Cancer Research Center and the University of Washington has ...
Shares of Seattle-based Dendreon Corp. rose nearly 13 percent on Wednesday after the biotechnology company said it would file a federal application to market Provenge, its lead product designed to ...
SEATTLE – September 20, 2016 – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve ...
First comprehensive assessment of DNA errors that drive advanced prostate cancer SEATTLE — Sept. 26, 2011 — A team of researchers at Fred Hutchinson Cancer Research Center and the University of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback